🔗 Share this article

Treasury head Rachel Reeves has announced she is preparing "targeted measures to deal with cost of living pressures" in the forthcoming Budget.

In comments to the BBC, she noted that lowering price rises is a shared duty of both the government and the Bank of England.

The United Kingdom's price growth is forecast to be the most elevated among the Group of Seven advanced economies this calendar year and the following year.

Possible Utility Cost Interventions

It is understood the administration could intervene to lower energy bills, such as by cutting the present 5% rate of VAT applied on energy supplies.

An additional option is to cut some of the regulatory levies presently added to household expenses.

Fiscal Constraints and Analyst Expectations

The administration will receive the latest draft from the independent fiscal watchdog, the Office for Budget Responsibility, on Monday, which will reveal how much space there is for such actions.

The consensus from most analysts is that Reeves will have to announce higher taxes or expenditure reductions in order to adhere to her voluntary debt limits.

Earlier on the same day, calculations indicated there was a £22 billion deficit for the Treasury chief to resolve, which is at the more modest range of forecasts.

"It is a joint responsibility between the Bank of England and the government to continue tackling some of the causes of inflation," Reeves stated to the BBC in the US capital, at the conferences of the International Monetary Fund and World Bank.

Revenue Pledges and Global Concerns

While much of the focus has been on expected tax rises, the chancellor said the most recent figures from the OBR had not changed her commitment to election pledges not to increase tax levels on income tax, VAT or social security contributions.

She blamed an "uncertain global environment" with increasing geopolitical and trade issues for the fiscal tax moves, probably to be targeted on those "wealthiest."

International Economic Disputes

Addressing concerns about the UK's economic relations with the Asian nation she said: "Our national security invariably are paramount."

Last week's statement by Chinese authorities to strengthen trade restrictions on critical minerals and other resources that are key for high-technology production led American leader Donald Trump to threaten an extra 100% tariff on goods from the Asian country, raising the prospect of an full-scale trade war between the two largest economies.

The American finance chief called China's decision "commercial pressure" and "a global supply chain power grab."

Inquired about considering the US offer to join its battle with China, the Chancellor said she was "deeply worried" by Chinese actions and called on the Beijing authorities "not to put up barriers and restrict access."

She said the action was "damaging for the international commerce and generates additional headwinds."

"I believe there are sectors where we need to confront China, but there are also valuable prospects to trade with China's economy, including banking sector and other areas of the economy. We've got to achieve that balance appropriate."

The Treasury chief also stated she was collaborating with other major economies "regarding our own critical minerals approach, so that we are reduced dependence."

NHS Medicine Costs and Investment

The Chancellor also recognized that the price the National Health Service spends on pharmaceuticals could rise as a consequence of ongoing negotiations with the Trump administration and its pharmaceutical firms, in exchange for lower tariffs and funding.

A number of the biggest global pharmaceutical manufacturers have said recently that they are either halting or abandoning operations in the UK, with several attributing the modest returns they are getting.

Last month, the government science advisor said the price the health service pays for medicines would have to increase to stop companies and pharmaceutical investment leaving the United Kingdom.

Reeves stated to media: "It has been observed due to the cost structure, that medical research, recent pharmaceuticals have not been offered in the UK in the manner that they are in other European countries."

"The objective is to ensure that people getting care from the National Health Service are can obtain the top essential drugs in the world. And so we are looking at all of that, and... looking to secure more funding into the UK."